TRPC3 and acute lymphoblastic leukemia: Previous studies from our group demonstrated that TRPC3 Ca2+ channel inhibitor (Pyr3) enhances dexamethasone sensitivity and apoptosis through the distraction of dexamethasone-mediated Ca2+ signaling in ALL cells and primary blasts [11].